Treatment with agonistic 3E1 mAb significantly reduced the survival of mice with JE and induced faster and enhanced proportions of neurological disorders (Fig. 1d), indicating that stimulating 4-1BB signaling exacerbates JE progression. This evidence concerns the gene TNFRSF9 and nervous system disorder.